{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:16:42Z","timestamp":1791314202497,"version":"4.3.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["e-aat.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Anaesthesiologica Taiwanica"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.aat.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T04:16:24Z","timestamp":1419567384000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Coagulation abnormalities in sepsis"],"prefix":"10.1016","volume":"53","author":[{"given":"Cheng-Ming","family":"Tsao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shung-Tai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aat.2014.11.002_bib1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.aat.2014.11.002_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1378\/chest.09-2205","article-title":"Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006","volume":"138","author":"Shen","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.aat.2014.11.002_bib3","first-page":"147","article-title":"Recent insights into the pathogenesis of bacterial sepsis","volume":"68","author":"Anas","year":"2010","journal-title":"Neth J Med"},{"key":"10.1016\/j.aat.2014.11.002_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2001-18863","article-title":"Disseminated intravascular coagulation in sepsis","volume":"27","author":"Hardaway","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.aat.2014.11.002_bib5","doi-asserted-by":"crossref","first-page":"e2010024","DOI":"10.4084\/mjhid.2010.024","article-title":"Sepsis-associated disseminated intravascular coagulation and thromboembolic disease","volume":"2","author":"Semeraro","year":"2010","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.aat.2014.11.002_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","article-title":"Sepsis, thrombosis and organ dysfunction","volume":"129","author":"Semeraro","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.aat.2014.11.002_bib7","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2011-02-337568","article-title":"Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense","volume":"118","author":"Loof","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood-2008-07-170506","article-title":"Reduced thrombin generation increases host susceptibility to group a streptococcal infection","volume":"113","author":"Sun","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib9","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.aat.2014.11.002_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/00365540310015935","article-title":"Cytokine cascade in sepsis","volume":"35","author":"Cavaillon","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.aat.2014.11.002_bib11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1152\/physrev.00037.2012","article-title":"Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding","volume":"93","author":"Iskander","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.aat.2014.11.002_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.tcam.2012.06.003","article-title":"The reciprocal relationship between inflammation and coagulation","volume":"27","author":"O'Brien","year":"2012","journal-title":"Top Companion Anim Med"},{"key":"10.1016\/j.aat.2014.11.002_bib13","doi-asserted-by":"crossref","first-page":"367284","DOI":"10.4061\/2011\/367284","article-title":"Tissue factor, blood coagulation, and beyond: an overview","volume":"2011","author":"Chu","year":"2011","journal-title":"Int J Inflamm"},{"key":"10.1016\/j.aat.2014.11.002_bib14","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.thromres.2010.01.042","article-title":"Cellular sources of tissue factor in endotoxemia and sepsis","volume":"125","author":"Pawlinski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.aat.2014.11.002_bib15","first-page":"73","article-title":"Role of dic in multiple organ failure","volume":"2","author":"Kidokoro","year":"2000","journal-title":"Int J Surg Investig"},{"key":"10.1016\/j.aat.2014.11.002_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2008.02841.x","article-title":"Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children","volume":"6","author":"Emonts","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib17","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1164\/ajrccm.156.6.9611100","article-title":"Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation","volume":"156","author":"Jourdain","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ccc.2005.04.004","article-title":"Sepsis and coagulation","volume":"21","author":"Aird","year":"2005","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.aat.2014.11.002_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1034\/j.1600-0609.2001.5790508.x","article-title":"Decreased plasma activity of antithrombin or protein c is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation","volume":"67","author":"Asakura","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.aat.2014.11.002_bib20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2353\/ajpath.2007.070104","article-title":"Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor","volume":"171","author":"Tang","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.aat.2014.11.002_bib21","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/cc4946","article-title":"Protein c concentrations in severe sepsis: an early directional change in plasma levels predicts outcome","volume":"10","author":"Shorr","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ccm.2008.06.006","article-title":"The coagulant response in sepsis","volume":"29","author":"Levi","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.aat.2014.11.002_bib23","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.4049\/jimmunol.1101094","article-title":"Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica","volume":"187","author":"Luo","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.aat.2014.11.002_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1160\/TH07-02-0117","article-title":"Fibrinolysis and host response in bacterial infections","volume":"98","author":"Bergmann","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00024382-200405000-00008","article-title":"Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury","volume":"21","author":"Kipnis","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.aat.2014.11.002_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1465-9921-7-41","article-title":"Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response","volume":"7","author":"Robriquet","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.aat.2014.11.002_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.CCM.0000153520.31562.48","article-title":"Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure","volume":"33","author":"Dhainaut","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","article-title":"A\u00a0multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cca.2014.04.020","article-title":"Disseminated intravascular coagulation: testing and diagnosis","volume":"436","author":"Wada","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.aat.2014.11.002_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MBC.0b013e32834ee170","article-title":"Application of thrombelastography in liver injury induced by endotoxin in rat","volume":"23","author":"Tsai","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.aat.2014.11.002_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1538-7836.2006.01715.x","article-title":"Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans","volume":"4","author":"Spiel","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib34","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/cc7765","article-title":"Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study","volume":"13","author":"Daudel","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SHK.0b013e318204bff6","article-title":"Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study","volume":"35","author":"Adamzik","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.aat.2014.11.002_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2012.09.003","article-title":"Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study","volume":"28","author":"Ostrowski","year":"2013","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib37","article-title":"Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia \u2014 a potential use of thrombelastography in endotoxin-induced sepsis","author":"Tsai","year":"2014","journal-title":"Blood Coagul Fibrinol"},{"issue":"36","key":"10.1016\/j.aat.2014.11.002_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock","volume":"2008","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.aat.2014.11.002_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.aat.2014.11.002_bib41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V95.4.1124.002k20_1124_1129","article-title":"Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia","volume":"95","author":"de Jonge","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib42","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/cc7747","article-title":"A\u00a0clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia","volume":"13","author":"Laterre","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib43","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1164\/rccm.201007-1167OC","article-title":"Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial","volume":"183","author":"Wunderink","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00001721-200212000-00001","article-title":"Antithrombin: a new look at the actions of a serine protease inhibitor","volume":"13","author":"Roemisch","year":"2002","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.aat.2014.11.002_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00024382-200115030-00010","article-title":"Antithrombin reduces mesenteric venular leukocyte interactions and small intestine injury in endotoxemic rats","volume":"15","author":"Neviere","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.aat.2014.11.002_bib46","first-page":"1553","article-title":"Inhibitory effects of antithrombin III against leukocyte rolling and infiltration during endotoxin-induced uveitis in rats","volume":"42","author":"Yamashiro","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.aat.2014.11.002_bib47","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1182\/blood.V99.11.4015","article-title":"Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells","volume":"99","author":"Oelschlager","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00003246-200101000-00027","article-title":"Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood","volume":"29","author":"Souter","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(07)70265-7","article-title":"Host\u2013pathogen interactions in sepsis","volume":"8","author":"van der Poll","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.aat.2014.11.002_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/jcp.1041440304","article-title":"Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells","volume":"144","author":"Kobayashi","year":"1990","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.aat.2014.11.002_bib51","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood.V95.4.1117.002k12_1117_1123","article-title":"Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli","volume":"95","author":"Minnema","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib52","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study","volume":"12","author":"Tagami","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s001340050642","article-title":"Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis","volume":"24","author":"Eisele","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib54","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.aat.2014.11.002_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib56","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.thromres.2012.03.021","article-title":"Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey","volume":"130","author":"Iba","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.aat.2014.11.002_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s13054-014-0497-x","article-title":"Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey","volume":"18","author":"Iba","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1538-7836.2007.02491.x","article-title":"Activated protein c","volume":"5","author":"Griffin","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib59","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib60","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1182\/blood-2004-10-3985","article-title":"Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation","volume":"105","author":"Feistritzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib61","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1097\/01.CCM.0000128037.72072.22","article-title":"Leukocyte and endothelial cell interactions in sepsis: relevance of the protein c pathway","volume":"32","author":"Joyce","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib62","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2174\/092986710791233706","article-title":"Regulation of the protein c anticoagulant and antiinflammatory pathways","volume":"17","author":"Rezaie","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.aat.2014.11.002_bib63","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1109-1245","article-title":"Sepsis: the dark side of histones","volume":"15","author":"Chaput","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.aat.2014.11.002_bib64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein c for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.aat.2014.11.002_bib65","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving sepsis campaign guidelines for management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib66","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00134-006-0086-9","article-title":"When a single pivotal trial should not be enough\u2014the case of drotrecogin-alfa (activated)","volume":"32","author":"Wiedermann","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib67","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.aat.2014.11.002_bib68","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/CCM.0b013e31823e9f45","article-title":"Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the surviving sepsis campaign","volume":"40","author":"Casserly","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib69","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1473-3099(12)70157-3","article-title":"Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression","volume":"12","author":"Kalil","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.aat.2014.11.002_bib70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.aat.2014.11.002_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.thromres.2012.11.025","article-title":"Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte\u2013endothelial interaction in a rat LPS model","volume":"131","author":"Iba","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.aat.2014.11.002_bib72","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand lewis y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.aat.2014.11.002_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1076029613492875","article-title":"Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin","volume":"20","author":"Hoppensteadt","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.aat.2014.11.002_bib75","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A\u00a0randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib76","unstructured":"Phase 3 safety and efficacy study of ART-123 in subjects with severe sepsis and coagulopathy. http:\/\/clinicaltrials.gov\/show\/NCT01598831 [accessed 12.12.14]."},{"key":"10.1016\/j.aat.2014.11.002_bib77","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.aat.2014.11.002_bib78","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/cc10228","article-title":"Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study","volume":"15","author":"Yamakawa","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib79","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(04)16259-4","article-title":"Drug intervention trials in sepsis: divergent results","volume":"363","author":"Polderman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.aat.2014.11.002_bib80","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3892\/etm.2013.1466","article-title":"Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study","volume":"7","author":"Liu","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.aat.2014.11.002_bib81","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s13054-014-0563-4","article-title":"Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2013.10.008","article-title":"Lipid mediators in immune dysfunction after severe inflammation","volume":"35","author":"Fullerton","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.aat.2014.11.002_bib83","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"Morris","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.aat.2014.11.002_bib84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/09537100802503368","article-title":"Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms","volume":"20","author":"Winning","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.aat.2014.11.002_bib85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CCM.0b013e3181b4275c","article-title":"Antiplatelet drugs and outcome in mixed admissions to an intensive care unit","volume":"38","author":"Winning","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1378\/chest.10-0891","article-title":"Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study","volume":"139","author":"Erlich","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.aat.2014.11.002_bib87","first-page":"782573","article-title":"Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study","volume":"2013","author":"Valerio-Rojas","year":"2013","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.aat.2014.11.002_bib88","doi-asserted-by":"crossref","first-page":"720254","DOI":"10.1155\/2012\/720254","article-title":"Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?","volume":"2012","author":"Losche","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.aat.2014.11.002_bib89","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e318246b9df","article-title":"Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis","volume":"40","author":"Eisen","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib90","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/cc11886","article-title":"Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients","volume":"17","author":"Sossdorf","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.aat.2014.11.002_bib91","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/09537104.2012.724482","article-title":"Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock","volume":"24","author":"Otto","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.aat.2014.11.002_bib92","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1097\/CCM.0b013e318225757f","article-title":"Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients","volume":"39","author":"Kor","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aat.2014.11.002_bib93","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.aat.2014.11.002_bib94","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138161206776361318","article-title":"Biology and pharmacology of the platelet p2y12 receptor","volume":"12","author":"Storey","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.aat.2014.11.002_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2013.07.002","article-title":"Use of antiplatelet agents in sepsis: a glimpse into the future","volume":"133","author":"Akinosoglou","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.aat.2014.11.002_bib96","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1189\/jlb.1012518","article-title":"LPS-induced systemic inflammation is more severe in P2Y12 null mice","volume":"95","author":"Liverani","year":"2014","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.aat.2014.11.002_bib97","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1538-7836.2009.03352.x","article-title":"Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis","volume":"7","author":"Seidel","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.aat.2014.11.002_bib98","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/09537104.2013.809520","article-title":"Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis","volume":"25","author":"Rahman","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.aat.2014.11.002_bib99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/CS20120194","article-title":"Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial","volume":"123","author":"Spiel","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.aat.2014.11.002_bib100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11239-012-0833-4","article-title":"Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness","volume":"35","author":"Gross","year":"2013","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.aat.2014.11.002_bib101","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.aat.2014.11.002_bib102","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/01.CIR.92.9.2373","article-title":"Blockade of platelet GPIIb\/IIIa receptors as an antithrombotic strategy","volume":"92","author":"Coller","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.aat.2014.11.002_bib103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10739680490266216","article-title":"Glycoprotein IIB\/IIIA-inhibition and microcirculatory alterations during experimental endotoxemia\u2014an intravital microscopic study in the rat","volume":"11","author":"Walther","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.aat.2014.11.002_bib104","doi-asserted-by":"crossref","first-page":"e41549","DOI":"10.1371\/journal.pone.0041549","article-title":"Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb\/IIIa blockade","volume":"7","author":"Sharron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.aat.2014.11.002_bib105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1160\/TH03-04-0233","article-title":"Blockade of GPIIb\/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia","volume":"90","author":"Derhaschnig","year":"2003","journal-title":"Thromb Haemost"}],"container-title":["Acta Anaesthesiologica Taiwanica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875459714001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875459714001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T11:31:27Z","timestamp":1598614287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875459714001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1875459714001106"],"URL":"https:\/\/doi.org\/10.1016\/j.aat.2014.11.002","relation":{},"ISSN":["1875-4597"],"issn-type":[{"value":"1875-4597","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation abnormalities in sepsis","name":"articletitle","label":"Article Title"},{"value":"Acta Anaesthesiologica Taiwanica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aat.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}